KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for Hims & Hers Health (HIMS) over the last 7 years, with Q3 2025 value amounting to $345.8 million.

  • Hims & Hers Health's Cash & Equivalents rose 10890.66% to $345.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $345.8 million, marking a year-over-year increase of 10890.66%. This contributed to the annual value of $220.6 million for FY2024, which is 12819.9% up from last year.
  • Latest data reveals that Hims & Hers Health reported Cash & Equivalents of $345.8 million as of Q3 2025, which was up 10890.66% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's Cash & Equivalents registered a high of $1.1 billion during Q2 2025, and its lowest value of $46.8 million during Q4 2022.
  • Over the past 5 years, Hims & Hers Health's median Cash & Equivalents value was $88.2 million (recorded in 2021), while the average stood at $167.0 million.
  • Per our database at Business Quant, Hims & Hers Health's Cash & Equivalents soared by 763313.07% in 2021 and then plummeted by 4863.69% in 2022.
  • Hims & Hers Health's Cash & Equivalents (Quarter) stood at $71.8 million in 2021, then crashed by 34.84% to $46.8 million in 2022, then skyrocketed by 106.67% to $96.7 million in 2023, then surged by 128.2% to $220.6 million in 2024, then skyrocketed by 56.76% to $345.8 million in 2025.
  • Its last three reported values are $345.8 million in Q3 2025, $1.1 billion for Q2 2025, and $273.7 million during Q1 2025.